View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Autism Spectrum Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 10, 2023
2 min read
Save

Study sees link between lithium in water and autism that ‘requires further scrutiny’

Study sees link between lithium in water and autism that ‘requires further scrutiny’

A study of more than 50,000 children born over a 14-year period in Denmark found that children born to mothers who were exposed to higher levels of lithium in their drinking water were moderately more likely to develop autism.

SPONSORED CONTENT
April 07, 2023
2 min read
Save

Targeted cognitive training improves working memory, information processing in autism

Targeted cognitive training improves working memory, information processing in autism

Targeted cognitive training increased auditory memory, processing speed and perception among adolescents and young adults with autism spectrum disorder, according to data published in the Journal of Clinical Medicine.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
February 27, 2023
2 min read
Save

Maternal primary immunodeficiency linked to offspring’s psychiatric disorders, suicidality

Maternal primary immunodeficiency linked to offspring’s psychiatric disorders, suicidality

Children born to mothers, not fathers, with primary antibody immunodeficiencies had greater risks for certain psychiatric disorders and for suicidal behavior, according to data published in JAMA Psychiatry.

SPONSORED CONTENT
February 17, 2023
1 min read
Save

Canadian biotech firm granted exemption to initiate phase 2 psilocybin study

Canadian biotech firm granted exemption to initiate phase 2 psilocybin study

Nova Mentis Life Science Corp. has received an exemption under Section 56 of the Health Canada Controlled Drugs and Substances Act to advance a phase 2a clinical trial examining oral microdose psilocybin therapy for fragile X syndrome.

SPONSORED CONTENT
February 17, 2023
1 min read
Save

Zelira Therapeutics receives funding for FDA trials of cannabinoid drug for ASD

Zelira Therapeutics receives funding for FDA trials of cannabinoid drug for ASD

Biopharmaceutical company Zelira Therapeutics has received $8.6 million in funding for the study of its cannabinoid drug for use in patients with autism spectrum disorder, according to a company press release.

SPONSORED CONTENT
January 26, 2023
3 min read
Save

Autism rates jump, especially among children without co-occurring intellectual disability

Autism rates jump, especially among children without co-occurring intellectual disability

The estimated prevalence of autism among 8-year-olds in a New Jersey study more than tripled during a 6-year period, including a fivefold increase in children with autism who do not have a co-occurring intellectual disability.

SPONSORED CONTENT
January 13, 2023
1 min read
Save

LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism

LinusBio raises $16M for novel platform to aid diagnosis, treatment of ALS, autism

LinusBio announced it has raised over $16 million in Series A funding to deliver technology that combines genomics, the environment and biological response to help diagnose and monitor the progression of disorders such as ALS and autism.

SPONSORED CONTENT
January 13, 2023
2 min read
Save

Antipsychotic prescriptions for children increased by 3.3% annually over 2 decades

Antipsychotic prescriptions for children increased by 3.3% annually over 2 decades

The prevalence of all antipsychotic prescriptions prescribed to those aged 3 to 18 years increased by an average of 3.3% annually from 2000 to 2019, researchers reported in The Lancet Psychiatry.

SPONSORED CONTENT
December 23, 2022
1 min read
Save

KGK Sciences receives approval for psilocybin clinical trial in Canada

KGK Sciences receives approval for psilocybin clinical trial in Canada

KGK Sciences Inc. received a no objection letter from Health Canada to proceed with a phase 2a clinical trial evaluating the use of psilocybin for fragile X syndrome, the leading genetic cause of autism spectrum disorder.

SPONSORED CONTENT
December 13, 2022
2 min read
Save

Deep learning may help predict mental disorder diagnosis

Deep learning may help predict mental disorder diagnosis

A multidiagnostic prediction model developed using deep learning was highly predictive of mental disorder diagnosis, according to new data published in JAMA Psychiatry.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails